Targeted Plasma Metabolite Profiling of Metformin in Healthy Korean Volunteers
![]() ![]() |
Lihm, Ho-Seob
(Department of Family Medicine, Kosin University College of Medicine)
Cha, Jaemin (Department of Biomedical Science, Kyungpook National University Graduate School) Seo, Jeong Ju (Department of Biomedical Science, Kyungpook National University Graduate School) Park, Jeonghyeon (Department of Biomedical Science, Kyungpook National University Graduate School) Lee, Joomi (Department of Biomedical Science, Kyungpook National University Graduate School) Lee, Hae Won (Clinical Trial Center, Kyungpook National University Hospital) Bae, Kyun Seop (Department of Clinical Pharmacology & Therapeutics, Asan Medical Center) Kim, Woomi (Department of Pharmacology, Kosin University College of Medicine) Yoon, Young-Ran (Department of Biomedical Science, Kyungpook National University Graduate School) |
1 | Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, Furlong TJ, Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE, Timmins P, Williams KM. Clinical pharmacokinetics of metformin. Clin Pharmacokinet, 2011;50(2):81-98 DOI ScienceOn |
2 | Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care, 2011;34(6): 1431-1437. DOI ScienceOn |
3 | Kruse JA. Metformin-associated lactic acidosis. J Emerg Med. 2001;20(3):267-272. DOI ScienceOn |
4 | Stades AM, Heikens JT, Erkelens DW, Holleman F, Hoekstra JB. Metformin and lactic acidosis: cause or coincidence? A review of case reports. J Intern Med, 2004;255(2): 179-187. DOI |
5 | Chui W. Metformin and contrast media. The Hongkong Medical Diary, 2006;11(6):19-20. |
6 | Marchetti P, Masiello P, Benzi L, Cecchetti P, Fierabracci V, Giannarelli R, Gregorio F, Brunetti P, Navalesi R. Effects of metformin therapy on plasma amino acid pattern in patients with maturity-onset diabetes. Drugs Exp Clin Res, 1989;15(11-12):565-570. |
7 | Johnson AB, Webster JM, Sum CF, Heseltine L, Argyraki M, Cooper BG, Taylor R. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetes patients. Metabolism, 1993;42(9): 1217-1222. DOI ScienceOn |
8 | Cai S, Huo T, Li N, Xiong Z, Li F. Lysophosphatidylcholine- biomarker of metformin action: studied using UPLC/MS/MS. Biomed Chromatogr, 2009;23(7):782-786. DOI ScienceOn |
9 | United Kingdom Prospective Diabetes Study (UKPDS). Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ, 1995;310(6972):83-88. DOI ScienceOn |
10 | United Kingdom Prospective Diabetes Study (UKPDS). A randomized trial of efficacy of early addition of metformin in sulfonylureatreated type 2 diabetes. Diabetes Care, 1998; 21(1):87-92. DOI ScienceOn |
11 | Glueck CJ, Fontaine RN, Wang P, Subbiah MT, Weber K, Illig E, Streicher P, Sieve-Smith L, Tracy TM, Lang JE, McCullough P. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism, 2001; 50(7):856-861. DOI ScienceOn |
12 | United Kingdom Prospective Diabetes Study (UKPDS). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 1998;352(9131):854-865. DOI ScienceOn |
13 | Liu F, Lu JX, Tang JL, Li L, Lu HJ, Hou XH, Jia WP, Xiang KS. Relationship of plasma creatinine and lactic acid in type 2 diabetic patients without renal dysfunction. Chin Med J (Engl), 2009;122(21):2547-2553. |
14 | Tahrani AA, Varughese GI, Scarpello JH, Hanna FW. Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? BMJ, 2007;335(7618):508-512. DOI |
15 | Jeong BC. Metabolomics in disease researches. Molecular and Cellular Biology News. 2006;3: 17-27. (Korean) |
![]() |